Pharmacoepidemiology and pharmacovigilance: synergistic tools to better Investigate drug safety
Pharmacoepidemiology and Pharmacovigilance: Synergistic Tools to Better Investigate Drug Safety examines the role of pharmacoepidemiologic studies in drug development and its use as a prevention tool in pharmacovigilance activities. The book introduces the various epidemiologic tools and study desig...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
London
Academic Press
[2019]
|
Schlagworte: | |
Online-Zugang: | Volltext |
Zusammenfassung: | Pharmacoepidemiology and Pharmacovigilance: Synergistic Tools to Better Investigate Drug Safety examines the role of pharmacoepidemiologic studies in drug development and its use as a prevention tool in pharmacovigilance activities. The book introduces the various epidemiologic tools and study designs commonly used for the surveillance of drug-related adverse effects and reviews the strengths and weaknesses of each. Criticisms surrounding pharmacoepidemiologic research and issues that often interfere or complicate the conduct and interpretation of these studies are also explored. Case studies illustrate the passive and active surveillance of adverse drug reactions in clinical situations, covering important pharmacoepidemiologic concepts like health risk management and safety. The book helps pharmaceutical industry groups engaged in drug safety, clinical investigators, medical evaluators and those seeking regulatory approval enhance the safety of the drug development process for all patient populations |
Beschreibung: | Includes bibliographical references and index |
Beschreibung: | 1 online resource |
ISBN: | 9780128163818 012816381X 9780128161838 0128161833 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV045383595 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 181228s2019 |||| o||u| ||||||eng d | ||
020 | |a 9780128163818 |9 978-0-12-816381-8 | ||
020 | |a 012816381X |9 0-12-816381-X | ||
020 | |a 9780128161838 |9 978-0-12-816183-8 | ||
020 | |a 0128161833 |9 0-12-816183-3 | ||
035 | |a (ZDB-33-ESD)on1057893431 | ||
035 | |a (ZDB-33-EBS)on1057893431 | ||
035 | |a (OCoLC)1057893431 | ||
035 | |a (DE-599)BVBBV045383595 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
082 | 0 | |a 615.7042 |2 23 | |
100 | 1 | |a Nour, Sabrina |e Verfasser |4 aut | |
245 | 1 | 0 | |a Pharmacoepidemiology and pharmacovigilance |b synergistic tools to better Investigate drug safety |c Sabrina Nour, Gilles Plourde |
264 | 1 | |a London |b Academic Press |c [2019] | |
264 | 4 | |c © 2019 | |
300 | |a 1 online resource | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
500 | |a Includes bibliographical references and index | ||
520 | |a Pharmacoepidemiology and Pharmacovigilance: Synergistic Tools to Better Investigate Drug Safety examines the role of pharmacoepidemiologic studies in drug development and its use as a prevention tool in pharmacovigilance activities. The book introduces the various epidemiologic tools and study designs commonly used for the surveillance of drug-related adverse effects and reviews the strengths and weaknesses of each. Criticisms surrounding pharmacoepidemiologic research and issues that often interfere or complicate the conduct and interpretation of these studies are also explored. Case studies illustrate the passive and active surveillance of adverse drug reactions in clinical situations, covering important pharmacoepidemiologic concepts like health risk management and safety. The book helps pharmaceutical industry groups engaged in drug safety, clinical investigators, medical evaluators and those seeking regulatory approval enhance the safety of the drug development process for all patient populations | ||
650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
650 | 4 | |a Pharmacoepidemiology | |
650 | 4 | |a Pharmacology | |
650 | 4 | |a Drugs |x Side effects | |
650 | 4 | |a Drug interactions | |
700 | 1 | |a Plourde, Gilles |e Sonstige |4 oth | |
856 | 4 | 0 | |u https://www.sciencedirect.com/science/book/9780128161838 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-33-ESD |a ZDB-33-EBS | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-030769928 |
Datensatz im Suchindex
_version_ | 1804179237022728192 |
---|---|
any_adam_object | |
author | Nour, Sabrina |
author_facet | Nour, Sabrina |
author_role | aut |
author_sort | Nour, Sabrina |
author_variant | s n sn |
building | Verbundindex |
bvnumber | BV045383595 |
collection | ZDB-33-ESD ZDB-33-EBS |
ctrlnum | (ZDB-33-ESD)on1057893431 (ZDB-33-EBS)on1057893431 (OCoLC)1057893431 (DE-599)BVBBV045383595 |
dewey-full | 615.7042 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615.7042 |
dewey-search | 615.7042 |
dewey-sort | 3615.7042 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02521nmm a2200445zc 4500</leader><controlfield tag="001">BV045383595</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">181228s2019 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780128163818</subfield><subfield code="9">978-0-12-816381-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">012816381X</subfield><subfield code="9">0-12-816381-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780128161838</subfield><subfield code="9">978-0-12-816183-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0128161833</subfield><subfield code="9">0-12-816183-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-33-ESD)on1057893431</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-33-EBS)on1057893431</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1057893431</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV045383595</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.7042</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Nour, Sabrina</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmacoepidemiology and pharmacovigilance</subfield><subfield code="b">synergistic tools to better Investigate drug safety</subfield><subfield code="c">Sabrina Nour, Gilles Plourde</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London</subfield><subfield code="b">Academic Press</subfield><subfield code="c">[2019]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Pharmacoepidemiology and Pharmacovigilance: Synergistic Tools to Better Investigate Drug Safety examines the role of pharmacoepidemiologic studies in drug development and its use as a prevention tool in pharmacovigilance activities. The book introduces the various epidemiologic tools and study designs commonly used for the surveillance of drug-related adverse effects and reviews the strengths and weaknesses of each. Criticisms surrounding pharmacoepidemiologic research and issues that often interfere or complicate the conduct and interpretation of these studies are also explored. Case studies illustrate the passive and active surveillance of adverse drug reactions in clinical situations, covering important pharmacoepidemiologic concepts like health risk management and safety. The book helps pharmaceutical industry groups engaged in drug safety, clinical investigators, medical evaluators and those seeking regulatory approval enhance the safety of the drug development process for all patient populations</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacoepidemiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Side effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug interactions</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Plourde, Gilles</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.sciencedirect.com/science/book/9780128161838</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-33-ESD</subfield><subfield code="a">ZDB-33-EBS</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030769928</subfield></datafield></record></collection> |
id | DE-604.BV045383595 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:16:40Z |
institution | BVB |
isbn | 9780128163818 012816381X 9780128161838 0128161833 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030769928 |
oclc_num | 1057893431 |
open_access_boolean | |
physical | 1 online resource |
psigel | ZDB-33-ESD ZDB-33-EBS |
publishDate | 2019 |
publishDateSearch | 2019 |
publishDateSort | 2019 |
publisher | Academic Press |
record_format | marc |
spelling | Nour, Sabrina Verfasser aut Pharmacoepidemiology and pharmacovigilance synergistic tools to better Investigate drug safety Sabrina Nour, Gilles Plourde London Academic Press [2019] © 2019 1 online resource txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index Pharmacoepidemiology and Pharmacovigilance: Synergistic Tools to Better Investigate Drug Safety examines the role of pharmacoepidemiologic studies in drug development and its use as a prevention tool in pharmacovigilance activities. The book introduces the various epidemiologic tools and study designs commonly used for the surveillance of drug-related adverse effects and reviews the strengths and weaknesses of each. Criticisms surrounding pharmacoepidemiologic research and issues that often interfere or complicate the conduct and interpretation of these studies are also explored. Case studies illustrate the passive and active surveillance of adverse drug reactions in clinical situations, covering important pharmacoepidemiologic concepts like health risk management and safety. The book helps pharmaceutical industry groups engaged in drug safety, clinical investigators, medical evaluators and those seeking regulatory approval enhance the safety of the drug development process for all patient populations MEDICAL / Pharmacology bisacsh Pharmacoepidemiology Pharmacology Drugs Side effects Drug interactions Plourde, Gilles Sonstige oth https://www.sciencedirect.com/science/book/9780128161838 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Nour, Sabrina Pharmacoepidemiology and pharmacovigilance synergistic tools to better Investigate drug safety MEDICAL / Pharmacology bisacsh Pharmacoepidemiology Pharmacology Drugs Side effects Drug interactions |
title | Pharmacoepidemiology and pharmacovigilance synergistic tools to better Investigate drug safety |
title_auth | Pharmacoepidemiology and pharmacovigilance synergistic tools to better Investigate drug safety |
title_exact_search | Pharmacoepidemiology and pharmacovigilance synergistic tools to better Investigate drug safety |
title_full | Pharmacoepidemiology and pharmacovigilance synergistic tools to better Investigate drug safety Sabrina Nour, Gilles Plourde |
title_fullStr | Pharmacoepidemiology and pharmacovigilance synergistic tools to better Investigate drug safety Sabrina Nour, Gilles Plourde |
title_full_unstemmed | Pharmacoepidemiology and pharmacovigilance synergistic tools to better Investigate drug safety Sabrina Nour, Gilles Plourde |
title_short | Pharmacoepidemiology and pharmacovigilance |
title_sort | pharmacoepidemiology and pharmacovigilance synergistic tools to better investigate drug safety |
title_sub | synergistic tools to better Investigate drug safety |
topic | MEDICAL / Pharmacology bisacsh Pharmacoepidemiology Pharmacology Drugs Side effects Drug interactions |
topic_facet | MEDICAL / Pharmacology Pharmacoepidemiology Pharmacology Drugs Side effects Drug interactions |
url | https://www.sciencedirect.com/science/book/9780128161838 |
work_keys_str_mv | AT noursabrina pharmacoepidemiologyandpharmacovigilancesynergistictoolstobetterinvestigatedrugsafety AT plourdegilles pharmacoepidemiologyandpharmacovigilancesynergistictoolstobetterinvestigatedrugsafety |